Osher Investimentos has announced a strategic co-investment in Farmax, a leading Brazilian beauty and wellness company, in collaboration with Lazuli Partners and Vidya Capital, aiming to further accelerate the company's growth through M&As and enhanced marketing efforts.
Target Company Overview
Osher Investimentos is pleased to announce its co-investment in Farmax, a prominent player in the Brazilian beauty, health, and wellness market. Farmax excels in various segments including skincare, hair care, and dietary supplements. The company has been experiencing rapid growth, driven by its commitment to quality and innovation in its product offerings.
This strategic partnership, involving Lazuli Partners and Vidya Capital, aims to further accelerate Farmax's growth trajectory. The plan includes a robust strategy focusing on mergers and acquisitions (M&As), alongside increasing investments in marketing and expanding production capacity.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Brazil
The Brazilian beauty and wellness industry is one of the largest in the world, having maintained resilient growth even in challenging economic
Similar Deals
Pátria Investimentos → Atakarejo
2023
General Atlantic → Balaji Wafers
2026
Osher Investimentos
invested in
Farmax
in
in a Strategic Partnership deal